PUBLISHER: 360iResearch | PRODUCT CODE: 1303303

PUBLISHER: 360iResearch | PRODUCT CODE: 1303303

Bifurcation Lesions Market by Type (One-Stent, Two-Stent), Application (Coronary Vascular, Peripheral Vascular) - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

PUBLISHED: June 12, 2023

PAGES: 184 Pages

DELIVERY TIME: 1-2 business days

SELECT AN OPTION

The Global Bifurcation Lesions Market is forecasted to grow significantly, with a projected USD 3,234.17 million in 2023 at a CAGR of 10.56% and expected to reach a staggering USD 6,560.93 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Bifurcation Lesions Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Bifurcation Lesions Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across One-Stent and Two-Stent. The Two-Stent is projected to witness significant market share during forecast period.

Based on Application, market is studied across Coronary Vascular and Peripheral Vascular. The Peripheral Vascular is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Bifurcation Lesions Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Bifurcation Lesions Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Bifurcation Lesions Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Bifurcation Lesions Market?

4. What is the competitive strategic window for opportunities in the Global Bifurcation Lesions Market?

5. What are the technology trends and regulatory frameworks in the Global Bifurcation Lesions Market?

6. What is the market share of the leading vendors in the Global Bifurcation Lesions Market?

7. What modes and strategic moves are considered suitable for entering the Global Bifurcation Lesions Market?

Product Code: MRR-BD6F81433E92

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Bifurcation Lesions Market, by Type, 2022 vs 2030
4.3. Bifurcation Lesions Market, by Application, 2022 vs 2030
4.4. Bifurcation Lesions Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Growing prevalence of coronary artery diseases globally
  - 5.1.1.2. Rising elderly population and the medical ailments associated with age
  - 5.1.1.3. Improving healthcare infrastructure coupled with preference for minimally invasive surgeries
- 5.1.2. Restraints
  - 5.1.2.1. Lack of skilled professional in the industry
- 5.1.3. Opportunities
  - 5.1.3.1. Ongoing research and development toward introduction novel treatment techniques
  - 5.1.3.2. Surge in the number of clinical trials on balloons and stents
- 5.1.4. Challenges
  - 5.1.4.1. Stringent regulations and standards
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization

6. Bifurcation Lesions Market, by Type

6.1. Introduction
6.2. One-Stent
6.3. Two-Stent

7. Bifurcation Lesions Market, by Application

7.1. Introduction
7.2. Coronary Vascular
7.3. Peripheral Vascular

8. Americas Bifurcation Lesions Market

8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Bifurcation Lesions Market

9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Bifurcation Lesions Market

10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape

11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

13.1. Discussion Guide
13.2. License & Pricing

Product Code: MRR-BD6F81433E92

LIST OF FIGURES

FIGURE 1. BIFURCATION LESIONS MARKET RESEARCH PROCESS
FIGURE 2. BIFURCATION LESIONS MARKET SIZE, 2022 VS 2030
FIGURE 3. BIFURCATION LESIONS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 5. BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 6. BIFURCATION LESIONS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 7. BIFURCATION LESIONS MARKET DYNAMICS
FIGURE 8. BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 10. AMERICAS BIFURCATION LESIONS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. UNITED STATES BIFURCATION LESIONS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 12. ASIA-PACIFIC BIFURCATION LESIONS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. EUROPE, MIDDLE EAST & AFRICA BIFURCATION LESIONS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. BIFURCATION LESIONS MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 15. BIFURCATION LESIONS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

TABLE 1. BIFURCATION LESIONS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. BIFURCATION LESIONS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 5. BIFURCATION LESIONS MARKET SIZE, BY ONE-STENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 6. BIFURCATION LESIONS MARKET SIZE, BY TWO-STENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 8. BIFURCATION LESIONS MARKET SIZE, BY CORONARY VASCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. BIFURCATION LESIONS MARKET SIZE, BY PERIPHERAL VASCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. AMERICAS BIFURCATION LESIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 11. AMERICAS BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 12. AMERICAS BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 13. ARGENTINA BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 14. ARGENTINA BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 15. BRAZIL BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 16. BRAZIL BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 17. CANADA BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 18. CANADA BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 19. MEXICO BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 20. MEXICO BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 21. UNITED STATES BIFURCATION LESIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 22. UNITED STATES BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 23. UNITED STATES BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. ASIA-PACIFIC BIFURCATION LESIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 25. ASIA-PACIFIC BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 26. ASIA-PACIFIC BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. AUSTRALIA BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 28. AUSTRALIA BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. CHINA BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 30. CHINA BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. INDIA BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 32. INDIA BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. INDONESIA BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 34. INDONESIA BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. JAPAN BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 36. JAPAN BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. MALAYSIA BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38. MALAYSIA BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. PHILIPPINES BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 40. PHILIPPINES BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. SINGAPORE BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. SINGAPORE BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. SOUTH KOREA BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 44. SOUTH KOREA BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. TAIWAN BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 46. TAIWAN BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. THAILAND BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. THAILAND BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. VIETNAM BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. VIETNAM BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. EUROPE, MIDDLE EAST & AFRICA BIFURCATION LESIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 52. EUROPE, MIDDLE EAST & AFRICA BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53. EUROPE, MIDDLE EAST & AFRICA BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. DENMARK BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. DENMARK BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. EGYPT BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. EGYPT BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. FINLAND BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 59. FINLAND BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. FRANCE BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 61. FRANCE BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. GERMANY BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. GERMANY BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. ISRAEL BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. ISRAEL BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. ITALY BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. ITALY BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. NETHERLANDS BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. NETHERLANDS BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. NIGERIA BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 71. NIGERIA BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. NORWAY BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 73. NORWAY BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. POLAND BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. POLAND BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. QATAR BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. QATAR BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. RUSSIA BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 79. RUSSIA BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. SAUDI ARABIA BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 81. SAUDI ARABIA BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. SOUTH AFRICA BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. SOUTH AFRICA BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. SPAIN BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. SPAIN BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. SWEDEN BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. SWEDEN BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. SWITZERLAND BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 89. SWITZERLAND BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. TURKEY BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. TURKEY BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. UNITED ARAB EMIRATES BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 93. UNITED ARAB EMIRATES BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. UNITED KINGDOM BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. UNITED KINGDOM BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. BIFURCATION LESIONS MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 97. BIFURCATION LESIONS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 98. BIFURCATION LESIONS MARKET LICENSE & PRICING

Have a question?

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Christine Sirois

Manager - Americas

+1-860-674-8796

SEE OUR FAQ